{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-21-006794","form_type":"8-K","ticker":"ZOMDF","cik":"0001684144","company_name":"Zomedica Corp.","filed_at":"2021-10-04T23:59:59+00:00","discovered_at":"2026-05-14T18:04:13.671701+00:00","generated_at":"2026-06-28T23:28:26.264366+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Zomedica appoints Larry Heaton as President and next CEO; Cohen to retire Nov 1","bullets":["Larry Heaton appointed President effective Oct 1, 2021; to become CEO on Nov 1, 2021.","Robert Cohen retires as CEO but remains on Board; retirement not related to any disagreements.","Heaton granted 10M stock options at $0.58 per share, vesting in 4 equal annual installments.","Annual base salary of $400,000, eligible for target discretionary bonus of $200,000.","Heaton brings 35+ years of executive experience from medical device and biotech industries."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-21-006794","json":"https://secwatch.observer/filing/0001171843-21-006794.json","markdown":"https://secwatch.observer/filing/0001171843-21-006794.md","text":"https://secwatch.observer/filing/0001171843-21-006794.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1684144/000117184321006794/0001171843-21-006794-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1684144/000117184321006794/f8k_100321.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T23:28:26.264366+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"94f8fa2cb7","claim":"Larry Heaton was appointed as Chief Executive Officer at Zomedica Corp..","evidence_excerpt":"On November 1, 2021, Mr. Heaton will succeed Robert Cohen as the Chief Executive Officer of the Company","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1684144/000117184321006794/0001171843-21-006794-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"succeed"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"d48ac2f7d4","claim":"Larry Heaton was appointed as President at Zomedica Corp..","evidence_excerpt":"On October 1, 2021, the Board of Directors of Zomedica Corp. (the “Company”) appointed Larry Heaton as the Company’s President, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1684144/000117184321006794/0001171843-21-006794-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"President"}],"fact_type":"executive_change"},{"claim_id":"de8731efe3","claim":"Robert Cohen retired as Chief Executive Officer at Zomedica Corp..","evidence_excerpt":"Mr. Cohen’s previously announced retirement as Chief Executive Officer will be effective.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1684144/000117184321006794/0001171843-21-006794-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"retired"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}